Herrmann John A III 4
4 · NOVAVAX INC · Filed Sep 28, 2022
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Herrmann John A III
SVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2022-09-26+3,973→ 8,373 total - Exercise/Conversion
Common Stock
2022-09-26+667→ 3,642 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2022-09-26−667→ 0 total(indirect: By Spouse)→ Common Stock (667 underlying) - Tax Payment
Common Stock
2022-09-26$18.87/sh−1,324$24,984→ 7,049 total - Tax Payment
Common Stock
2022-09-26$18.87/sh−258$4,868→ 3,384 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2022-09-26−3,973→ 0 total→ Common Stock (3,973 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date (the "Grant Date"), in each case subject to continued employment through such vesting date.
- [F4]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service with the Company through such vesting date.